NPI 1336193903: Open Payments
NPI 1336193903. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,992 in 37 payments from 7 companies in 2025. Trend: 2023 $2,546 · 2024 $3,849 · 2025 $3,992
Food & beverage: $2,742Speaker / faculty: $1,250
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 21 | $3,255 |
| BIOTRONIK NRO, Inc. | 9 | $477 |
| SI-BONE, INC. | 2 | $109 |
| ABBVIE INC. | 2 | $91 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| TerSera Therapeutics LLC | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
Products named: ACCURIAN, INCEPTIV, INTELLIS ADAPTIVESTIM, Prospera, QULIPTA, SYNCHROMEDII, INSPIRE, Prialt.
